The review found that multifaceted interventions , addressing several non-adherence factors , were comparatively more effective in improving medication adherence and glycaemic target in patients with T2D than single strategies .
However , interventions with similar components and those addressing similar non-adherence factors demonstrated mixed results , making it difficult to conclude on effective intervention strategies to promote adherence .
Educational strategies have remained the most popular intervention strategy , followed by behavioural , with affective components becoming more common in recent years .
There is a noticeable shift in the literature from using single to multifaceted intervention strategies addressing a range of factors impacting adherence to medications .
BACKGROUND Poor adherence to anti-diabetic medications contributes to suboptimal glycaemic control in patients with type 2 diabetes ( T2D ) .
A range of interventions have been developed to promote anti-diabetic medication adherence .
However , there has been very little focus on the characteristics of these interventions and how effectively they address factors that predict non-adherence .
In this systematic review we assessed the characteristics of interventions that aim ed to promote adherence to anti-diabetic medications .
Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team – a pilot study
Abstract Objective : To evaluate the feasibility and impact of a structured approach for community pharmacist input as a member of the multidisciplinary team caring for patients with type-2 diabetes and health professional providing advice on medication . Methods : Prospect i ve pretest-posttest single group study . Sixty-two patients on oral hypoglycaemic therapy , identified as regular customers of four Scottish ( UK ) community pharmacies , were recruited . Each patient underwent an initial assessment : review of medical general practice notes/community pharmacy PMR ( Patient medication record ) system and structured interview . St and ardised documentation was completed , a pharmaceutical care plan ( PCP ) prepared , peer- review ed and then discussed face-to-face with patients ' GPs ( general practitioners ) . A second ( final ) assessment was conducted 24 to 28 weeks from the initial interview . Main outcome measures : Pharmaceutical care issues ( PCIs ) throughout study period ; change in parameters from initial to final assessment : patient knowledge of oral hypoglycaemic and anti-hypertensive therapy ; HbA1c ; blood pressure ; total cholesterol ; medication compliance . Results : A total of 178 PCIs were identified ( mean [ range ] 2.9 [ 1–5 ] per patient ) and categorised : drug therapy problems ( n=76 ) ; monitoring ( n=21 ) ; and patient knowledge ( n=81 ) . Drug therapy problems discussed with the GPs were agreed for 74 ( 97 % ) and resolved for 55 ( 72 % ) at final assessment . Biological outcome measures were assessed for 59 patients ( 3 drop-outs ) . A reduction ( P < 0.05 ) in HbA1c , blood pressure and total cholesterol was observed over the study period . Patients knowledge was poor for oral hypoglycaemic therapy but improved ( initial-51 % , final-72 % , P < 0.05 ) . Conclusion : This study demonstrated a feasible pharmaceutical care model for diabetes patients in an European country . The results have shown the pharmacist to be effective and well accepted by GPs and patients
The review found that multifaceted interventions , addressing several non-adherence factors , were comparatively more effective in improving medication adherence and glycaemic target in patients with T2D than single strategies .
However , interventions with similar components and those addressing similar non-adherence factors demonstrated mixed results , making it difficult to conclude on effective intervention strategies to promote adherence .
Educational strategies have remained the most popular intervention strategy , followed by behavioural , with affective components becoming more common in recent years .
There is a noticeable shift in the literature from using single to multifaceted intervention strategies addressing a range of factors impacting adherence to medications .
BACKGROUND Poor adherence to anti-diabetic medications contributes to suboptimal glycaemic control in patients with type 2 diabetes ( T2D ) .
A range of interventions have been developed to promote anti-diabetic medication adherence .
However , there has been very little focus on the characteristics of these interventions and how effectively they address factors that predict non-adherence .
In this systematic review we assessed the characteristics of interventions that aim ed to promote adherence to anti-diabetic medications .